Alexandra Deschner
Architect for biotech navigating capital inflection points.
About Alexandra
Alexandra Deschner is an investor relations and capital markets strategist who helps biotech companies strengthen investor positioning, institutional readiness, and executive credibility during critical growth and financing stages. She operates at the intersection of corporate narrative, capital markets strategy, and executive positioning, helping organizations translate complex science into clear, investable investment theses that resonate with institutional investors and stakeholders. Her experience includes investor relations strategy, executive communications, capital markets positioning, shareholder engagement, investor infrastructure development, and institutional narrative alignment for growth-stage and publicly traded biotech organizations. Today, Alexandra works with life sciences companies navigating clinical milestones, financing events, market volatility, and increased investor scrutiny, helping leadership teams build the structure, messaging discipline, and market readiness required to operate with greater confidence and credibility. She is particularly focused on helping organizations establish institutional-grade investor relations infrastructure that improves strategic alignment, strengthens shareholder quality, and supports long-term market trust during moments when narrative clarity matters most.